Table 5.
Actively recruiting trials evaluating the value of interim PET/CT in advanced stage cHL
UK indicates United Kingdom; RATHL, Response Adapted Therapy using FDG-PET imaging in patients with advanced Hodgkin Lymphoma; NCI, National Cancer Institute; –ve, negative; +ve, positive.
